Skip to main content

Advertisement

Log in

Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Voriconazole is increasingly used as a first-line agent for empirical antifungal therapy of prolonged febrile neutropenia in paediatric cancer patients. We describe the case of a 9-year-old patient with stage IV Burkitt lymphoma, who developed pulmonary and splenic zygomycosis while receiving voriconazole for persistent febrile neutropenia. The causative agent, Absidia corymbifera, was identified by broad-range fungal PCR in a lung biopsy sample. The patient was successfully treated with a combination of partial resection of the left upper lobe and antifungal therapy with high-dose liposomal amphotericin B followed by oral itraconazole as demonstrated by resolving pulmonary infiltrates on serial high resolution CT scans. Conclusion:This case emphasises that the lack of in vitro activity of voriconazole against zygomycetes is clinically relevant. Failure of voriconazole in suspected fungal infection should be investigated for the possibility of zygomycosis. Broad-range polymerase chain reaction may be able to identify the causative organism when cultures remain sterile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

BAL :

bronchoalveolar lavage

HRCT :

high-resolution computed tomography

PET :

positron emission tomography

References

  1. Bennett JE, Powers J, Walsh T, Viscoli C, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Verweij P (2003) Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis 36: S117–S122

    Article  Google Scholar 

  2. Clement L, Salmon A, Mansuy L, Paczesny S, Bordigoni P (2004) Mucormycosis after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 33: S205

    Article  Google Scholar 

  3. Dannaoui E, Meletiadis, Mouton JW, Meis JFGM, Verweij PE (2003) In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 511: 45–52

    Article  Google Scholar 

  4. Dannaoui E, Meis JF, Leobenberg D, Verweij PE (2003) Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agent Chemother 47: 3647–3650

    Article  Google Scholar 

  5. Gebhard F, Chastagner P, Maillot D, Kures L, Georges JL, Schmitt C, Bordigoni P, Sommelet D (1995) Evolution favorable d’une mucormycose orbitonasosinusienne compliquant le traitement d’induction d’une leucémie aiguë lymphoblastique. Arch Pédiatr 2: 47–51

    Google Scholar 

  6. Grigull L, Beier R, Schrauder, Kirschner P, Loening L, Jack T, Welte K, Sykora KW, Schrappe M (2003) Invasive fungal infections are responsible for one-fifth of infectious death in children with ALL. Mycoses 46: 441–446

    Article  Google Scholar 

  7. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34: 730–751

    Article  PubMed  Google Scholar 

  8. Johnson EM, Szekely A, Warnock DW (1998) In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 42: 741–745

    Article  CAS  PubMed  Google Scholar 

  9. Leong KW, Crowley B, White B, Crotty GM, O’Brian DS, Keane C, McCann SR (1997) Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant 19: 513–515

    Article  Google Scholar 

  10. Marty FM, Cosimi LA, Baden LR (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 350: 950–951

    Article  Google Scholar 

  11. Parkyn T, McNinch AW, Riordan T, Mott M (2000) Zygomycosis in relapsed acute leukaemia. J Infect 41: 265–282

    Article  Google Scholar 

  12. Rickerts V, Loeffler J, Böhme A, Einsele H, Just-Nübling G (2001) Diagnosis of disseminated zygomycosis using a polymerase chain reaction assay. Eur J Clin Microbiol Infect Dis 20: 744–745

    Article  Google Scholar 

  13. Ryan M, Yeo S, Maguire A, Webb D, O’Marcaigh A, McDermott M, Butler K, O’Meara A (2001) Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia. Eur J Pediatr 160: 235–238

    Article  Google Scholar 

  14. Tobon AM, Arango M, Fernandez D, Restrepo A (2003) Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 36: 1488–1491

    Article  Google Scholar 

  15. Wali YA, Al Lamki Z, Al Kindi H, Taqi AM, Shah W, Soliman H, Zackaria M, Al Okbi H (2001) Successful outcome of invasive nasal sinus zygomycosis in a child with relapsed acute lymphoblastic leukaemia due to liposomal amphotericin B. Mycoses 44: 195–199

    Article  Google Scholar 

  16. Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR (2002) Voriconazole in treatment of aspergillosis, scedosporosis and other invasive fungal infections in children. Pediatr Infect Dis J 21: 240–248

    Article  Google Scholar 

  17. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdiere M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J (2002) Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346: 225–234

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Aebi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritz, N., Ammann, R.A., Aebischer, C.C. et al. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Eur J Pediatr 164, 231–235 (2005). https://doi.org/10.1007/s00431-004-1606-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-004-1606-7

Keywords

Navigation